ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Phone Number Listings Completed

September 21, 1979

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 14, 2000

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014

Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer

July 31, 2009

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006